The NHS is set to become the first health service in the world to routinely offer DNA tests, marking a big step towards more efficient treatment tailored to individuals.
From 1 October, “hospitals across England will be connected to specialist centres that read, analyse and interpret patient DNA to help diagnose rare diseases, match patients to the most effective treatments, and reduce adverse drug reactions”, reports The Guardian.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“Beyond its aim to bring patients the most effective treatments faster, the service is expected to generate a wealth of data on the interplay between DNA, health and lifestyles, which will become a powerful tool for research into cancer and other diseases,” says the newspaper.
Mark Caulfield, chief scientist at Genomic England and professor of cardiovascular genetics at the William Harvey Research Institute in London, said: “We are ushering in a new era of genomic health. This is a big step and it grows over the new two years. It’s a total transformation.”
Genomics England, a company formed by the Department of Health in 2013, has already set up seven genomic hubs across the country to deliver DNA tests on cancer, rare diseases and other conditions. The service will be offered in England initially, but could potentially be rolled out across the UK.
Further DNA tests under development could help identify patients who may have bad reactions to certain drugs, and to reveal the risk of severe early onset diseases such as Parkinson’s, multiple sclerosis and dementia.
“Research is ongoing into genetic tests that can be combined with other medical information to highlight patients most at risk of diseases such as breast cancer, diabetes and hypertension,” The Guardian adds.
-
'That message may seem unimpeachable'Instant Opinion Opinion, comment and editorials of the day
-
How is Chili's saving casual dining? Could others follow?Today's Big Question Value and TikTok virality bring in the diners
-
NASA is abandoning the climateThe Explainer Climate missions could be going dark
-
What to say to someone who has cancerThe Explainer Saying something is better than nothing but there are some things to avoid too
-
Anastrozole: the daily breast cancer pill tipped to save thousands of livesThe Explainer Existing treatment approved for preventative use under 'pioneering' NHS drug repurposing scheme
-
Five good-news cancer breakthroughs in 2023In Depth Cancer-sniffing ants, ‘Bond villain’ DNA, and vaccine trials are just a few exciting developments in cancer research this year
-
Neanderthal gene ‘caused up to a million Covid deaths’Speed Read Genetic tweak found in one in six Britons means cells in the lungs are slower to launch defences
-
Deborah James: tireless cancer campaigner dies aged 40In the Spotlight The bowel cancer campaigner raised millions for cancer research charities
-
The UK’s ‘emergency’ cancer battlefeature Study finds Britain is ‘among worst in the world’ at detecting disease early
-
Legalising assisted dying: a complex, fraught and ‘necessary’ debateSpeed Read The Assisted Dying Bill – which would allow doctors to assist in the deaths of terminally ill patients – has relevance for ‘millions’
-
Vaccinating children: it’s decision time for the health secretary as kids return to schoolSpeed Read Sajid Javid readying NHS England to roll out jab for children over 12, amid fears infections will rocket
